These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32339614)

  • 21. Compositional, structural, and functional alterations in pulmonary surfactant in surgical patients after the early onset of systemic inflammatory response syndrome or sepsis.
    Raymondos K; Leuwer M; Haslam PL; Vangerow B; Ensink M; Tschorn H; Schürmann W; Husstedt H; Rueckoldt H; Piepenbrock S
    Crit Care Med; 1999 Jan; 27(1):82-9. PubMed ID: 9934898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD14-positive extracellular vesicles in bronchoalveolar lavage fluid as a new biomarker of acute respiratory distress syndrome.
    Mahida RY; Price J; Lugg ST; Li H; Parekh D; Scott A; Harrison P; Matthay MA; Thickett DR
    Am J Physiol Lung Cell Mol Physiol; 2022 Apr; 322(4):L617-L624. PubMed ID: 35234046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Keratinocyte growth factor and hepatocyte growth factor in bronchoalveolar lavage fluid in acute respiratory distress syndrome patients.
    Stern JB; Fierobe L; Paugam C; Rolland C; Dehoux M; Petiet A; Dombret MC; Mantz J; Aubier M; Crestani B
    Crit Care Med; 2000 Jul; 28(7):2326-33. PubMed ID: 10921560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognosis of pathogen-proven acute respiratory distress syndrome diagnosed from a protocol that includes bronchoalveolar lavage: a retrospective observational study.
    Kyo M; Hosokawa K; Ohshimo S; Kida Y; Tanabe Y; Shime N
    J Intensive Care; 2020; 8():54. PubMed ID: 32714556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positive blood culture is not associated with increased mortality in patients with sepsis-induced acute respiratory distress syndrome.
    Yang SC; Liao KM; Chen CW; Lin WC
    Respirology; 2013 Nov; 18(8):1210-6. PubMed ID: 23692513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic iloprost for the treatment of acute respiratory distress syndrome (ARDS) (the ThIlo trial): a prospective, randomized, multicenter phase II study.
    Haeberle H; Prohaska S; Martus P; Straub A; Zarbock A; Marx G; Zago M; Giera M; Koeppen M; Rosenberger P
    Trials; 2020 Mar; 21(1):242. PubMed ID: 32131881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nebulised heparin for patients with or at risk of acute respiratory distress syndrome: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial.
    Dixon B; Smith RJ; Campbell DJ; Moran JL; Doig GS; Rechnitzer T; MacIsaac CM; Simpson N; van Haren FMP; Ghosh AN; Gupta S; Broadfield EJC; Crozier TME; French C; Santamaria JD;
    Lancet Respir Med; 2021 Apr; 9(4):360-372. PubMed ID: 33493448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical profile of ARDS.
    Vigg A; Mantri S; Vigg A; Vigg A
    J Assoc Physicians India; 2003 Sep; 51():855-8. PubMed ID: 14710968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of eosinophils in sepsis and acute respiratory distress syndrome: a scoping review.
    Al Duhailib Z; Farooqi M; Piticaru J; Alhazzani W; Nair P
    Can J Anaesth; 2021 May; 68(5):715-726. PubMed ID: 33495945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Dynamic measurement of volume of atelectasis area in the evaluation of the prognosis of patients with moderate-to-severe acute respiratory distress syndrome].
    Lu X; Han Y; Gao X; Wang F; Xu L
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Sep; 32(9):1056-1060. PubMed ID: 33081890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
    Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
    Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The alveolar fibroproliferative response in moderate to severe COVID-19-related acute respiratory distress syndrome and 1-yr follow-up.
    Zhang S; Boers LS; de Brabander J; van den Heuvel LB; Blok SG; Kullberg RFJ; Smids-Dierdorp BS; Dekker T; Aberson HL; Meijboom LJ; Vlaar APJ; Heunks L; Nossent EJ; van der Poll T; Bos LDJ; Duitman J;
    Am J Physiol Lung Cell Mol Physiol; 2024 Jan; 326(1):L7-L18. PubMed ID: 37933449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early risk factors and the role of fluid administration in developing acute respiratory distress syndrome in septic patients.
    Seethala RR; Hou PC; Aisiku IP; Frendl G; Park PK; Mikkelsen ME; Chang SY; Gajic O; Sevransky J
    Ann Intensive Care; 2017 Dec; 7(1):11. PubMed ID: 28116595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An increase in serum C18 unsaturated free fatty acids as a predictor of the development of acute respiratory distress syndrome.
    Bursten SL; Federighi DA; Parsons P; Harris WE; Abraham E; Moore EE; Moore FA; Bianco JA; Singer JW; Repine JE
    Crit Care Med; 1996 Jul; 24(7):1129-36. PubMed ID: 8674324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical usefulness of extravascular lung water and pulmonary vascular permeability index to diagnose and characterize pulmonary edema: a prospective multicenter study on the quantitative differential diagnostic definition for acute lung injury/acute respiratory distress syndrome.
    Kushimoto S; Taira Y; Kitazawa Y; Okuchi K; Sakamoto T; Ishikura H; Endo T; Yamanouchi S; Tagami T; Yamaguchi J; Yoshikawa K; Sugita M; Kase Y; Kanemura T; Takahashi H; Kuroki Y; Izumino H; Rinka H; Seo R; Takatori M; Kaneko T; Nakamura T; Irahara T; Saito N; Watanabe A;
    Crit Care; 2012 Dec; 16(6):R232. PubMed ID: 23232188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnostic value of mechanical power in patients with moderate to severe acute respiratory distress syndrome: an analysis using the data from MIMIC-III].
    Yan Y; Xie Y; Wang Y; Chen X; Sun Y; Du Z; Li X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Jan; 34(1):35-40. PubMed ID: 35307058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical study of early use of neuromuscular blocking agents in patients with severe sepsis and acute respiratory distress syndrome].
    Lyu G; Wang X; Jiang W; Cai T; Zhang Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 May; 26(5):325-9. PubMed ID: 24809261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long non-coding RNA THRIL predicts increased acute respiratory distress syndrome risk and positively correlates with disease severity, inflammation, and mortality in sepsis patients.
    Wang Y; Fu X; Yu B; Ai F
    J Clin Lab Anal; 2019 Jul; 33(6):e22882. PubMed ID: 31257645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early stabilizing alveolar ventilation prevents acute respiratory distress syndrome: a novel timing-based ventilatory intervention to avert lung injury.
    Roy S; Sadowitz B; Andrews P; Gatto LA; Marx W; Ge L; Wang G; Lin X; Dean DA; Kuhn M; Ghosh A; Satalin J; Snyder K; Vodovotz Y; Nieman G; Habashi N
    J Trauma Acute Care Surg; 2012 Aug; 73(2):391-400. PubMed ID: 22846945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.